Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 1990. Upgrade now.
Date Value
March 31, 2024 -13.10B
December 31, 2023 -14.08B
September 30, 2023 -15.88B
June 30, 2023 -16.51B
March 31, 2023 -6.146B
December 31, 2022 -4.96B
September 30, 2022 -15.26B
June 30, 2022 -15.36B
March 31, 2022 -16.99B
December 31, 2021 -16.56B
September 30, 2021 -9.284B
June 30, 2021 -10.38B
March 31, 2021 -8.553B
December 31, 2020 -9.443B
September 30, 2020 -5.428B
June 30, 2020 -3.082B
March 31, 2020 -4.625B
December 31, 2019 -2.629B
September 30, 2019 312.00M
June 30, 2019 1.781B
March 31, 2019 4.879B
December 31, 2018 4.314B
September 30, 2018 2.078B
June 30, 2018 1.089B
March 31, 2018 -711.00M
Date Value
December 31, 2017 2.679B
September 30, 2017 174.00M
June 30, 2017 -1.387B
March 31, 2017 -1.758B
December 31, 2016 -3.21B
September 30, 2016 -1.264B
June 30, 2016 -435.00M
March 31, 2016 3.588B
December 31, 2015 -4.758B
September 30, 2015 3.063B
June 30, 2015 -598.00M
March 31, 2015 -3.172B
December 31, 2014 -374.00M
September 30, 2014 -6.401B
June 30, 2014 -4.716B
March 31, 2014 -5.802B
December 31, 2013 -3.148B
September 30, 2013 -8.723B
June 30, 2013 -8.525B
March 31, 2013 -7.688B
December 31, 2012 -6.805B
September 30, 2012 -4.091B
June 30, 2012 -2.515B
March 31, 2012 -3.265B
December 31, 2011 -2.89B

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-16.99B
Minimum
Mar 2022
1.781B
Maximum
Jun 2019
-9.309B
Average
-9.364B
Median

Cash from Investing (TTM) Benchmarks

Amgen Inc -27.78B
Johnson & Johnson -2.901B
Eli Lilly and Co -7.642B
Pfizer Inc -33.86B
Moderna Inc 2.313B